natural glp-1 receptor agonists Frontiers GLP1 Receptor Agonists—Effects beyond Obesity
Description
Funding Statement This work has been funded by Novo-Nordisk
About the review This review aims to simultaneously promote GLP-1 RA research and enhance users' understanding by synthesizing evidence from recent landmark trials, thereby providing a comprehensive picture of the potential of these drugs as more than just metabolic modulators
Summary Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) have transformed obesity management, offering substantial weight loss and metabolic benefits
10.1186/s40885-019-0132-x 65 OhY
Addressing mental health can also be an important tool in weight loss
